BioVariance is a partner in the EU-funded project “BEATsep”, which aims to combat the long-term effects of sepsis.
The research consortium BEATsep, established by the Cellular and Molecular Immunoregulation (CMI) research team at the International Clinical Research Centre (ICRC) at St. Anne’s University